Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant Nlrp3 Inhibitor Vtx3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
Ventyx生物科學宣佈神經元穿透性Nlrp3抑制劑Vtx3232的陽性臨床前數據，顯示肥胖的逆轉和心臟代謝和炎症標記的改善。